Loading clinical trials...
Loading clinical trials...
A Phase I, Open Label, Multicenter, Dose Finding Study of IDH305 With Standard of Care in IDH1 Mutant Acute Myeloid Leukemia
Conditions
Interventions
IDH305
Start Date
August 26, 2016
Primary Completion Date
November 29, 2016
Completion Date
November 29, 2016
Last Updated
April 10, 2019
NCT06660368
NCT05143996
NCT05768932
NCT07198867
NCT06398457
NCT07023588
Lead Sponsor
Novartis Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions